1814 EFFICIENCY OF FLEXIBLE URETERORENOSCOPY IN TREATMENT OF KIDNEY STONES IN PATIENTS WITH CHRONIC KIDNEY DISEASE

作者
Emrah Yürük,Murat Binbay,Faruk Özgör,Akif Erbin,Y. Berberoğlu,Ahmet Yaser Müslümanoğlu
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:189 (4S)
标识
DOI:10.1016/j.juro.2013.02.2177
摘要

You have accessJournal of UrologyStone Disease: SWL, Ureteroscopy or Percutaneous Stone Removal (III)1 Apr 20131814 EFFICIENCY OF FLEXIBLE URETERORENOSCOPY IN TREATMENT OF KIDNEY STONES IN PATIENTS WITH CHRONIC KIDNEY DISEASE Emrah Yuruk, Murat Binbay, Faruk Ozgor, Akif Erbin, Yalcin Berberoglu, and Ahmet Yaser Muslumanoglu Emrah YurukEmrah Yuruk Istanbul, Turkey More articles by this author , Murat BinbayMurat Binbay Istanbul, Turkey More articles by this author , Faruk OzgorFaruk Ozgor Istanbul, Turkey More articles by this author , Akif ErbinAkif Erbin Istanbul, Turkey More articles by this author , Yalcin BerberogluYalcin Berberoglu Istanbul, Turkey More articles by this author , and Ahmet Yaser MuslumanogluAhmet Yaser Muslumanoglu Istanbul, Turkey More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2013.02.2177AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES We evaluated the effects of kidney stone treatment with flexible ureterorenoscopy (f-URS) on patients with chronic kidney disease. METHODS Data of patients who underwent ureterorenoscopic kidney stone treatment were collected. Estimated glomerular filtration rate (eGFR) was calculated using chronic kidney disease epidemiology collaboration (CKD-EPI) formula for each patient. Patients were staged according to eGFR using National Kidney Foundation guidelines. Stage 3 and more was accepted as chronic kidney disease (CKD). Operative findings, postoperative complications and 3rd month success rates as well as overall eGFR change were documented. Success was evaluated with non-contrast enhanced computerized tomography in all cases. RESULTS Overall 339 patients were treated and 62 of them had stage 3 or more CKD. Male/female ratio was 24/38. Mean patient age was 56.79±11.45 (range: 14-80) years. Co-morbidities including hypertension, diabetes mellitus, chronic heart or lung disease were seen in 43 patients. Previous stone intervention including percutaneous nephrolithotomy and shock-wave lithotripsy was performed in 39 patients and 11 had solitary kidney. Mean stone size was 173.56±102.08 (range: 66-620) mm2. Stones were located in upper calyx in 7, middle calyx in 7, lower pole in 18, pelvis in 6, and multiple calyx in 24 patients. Operative time was 49.08±25.76 (range: 12-135) minutes. Fluoroscopic screening time was 2.90±2.05 (range: 0.5-15) minutes. Access sheath was used in 54 patients. Overall complications were seen in 12 patients. Mucosal tearing was seen in 8 patients and was the most common complication. Postoperative complications were also seen in 12 patients and colicky pain was the most common postoperative complication accounting in 9 patients. DJ catheter was used in 59 patients. Preoperative mean eGFR rate was 48.16±8.71 (range: 19-59) ml/min/1.73m2 and mean CKD stage was 3.01±0.12. Early postoperative mean eGFR and CKD stage was 49.0±11.71 (range: 17-72) ml/min/1.73m2 and 2.80±0.43, respectively while mean eGFR increased to 53.98±9.06 (range: 35-73) ml/min/1.73m2, and mean CKD stage decreased to 2.64±0.51 at 3rd month control. After the surgery, 40 patients were stone free while 14 had fragments less than 2mm in largest diameter. 8 patients had postoperative auxiliary treatment. Hospitalization time was 25.70±25.62 (range: 7-180) hours. At 3rd month control, 12 more patients were stone free and overall 83.8% SF rate was achieved with only one session fURS. CONCLUSIONS Flexible ureterorenoscopy, as in normal population, can be safely and effectively be used in chronically diseased kidneys. Although eGFR remains stable at the end of first week, the overall kidney function gets better at 3rd month control. © 2013 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 189Issue 4SApril 2013Page: e746 Advertisement Copyright & Permissions© 2013 by American Urological Association Education and Research, Inc.MetricsAuthor Information Emrah Yuruk Istanbul, Turkey More articles by this author Murat Binbay Istanbul, Turkey More articles by this author Faruk Ozgor Istanbul, Turkey More articles by this author Akif Erbin Istanbul, Turkey More articles by this author Yalcin Berberoglu Istanbul, Turkey More articles by this author Ahmet Yaser Muslumanoglu Istanbul, Turkey More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AireenBeryl531完成签到,获得积分0
刚刚
Cristol发布了新的文献求助10
1秒前
科研通AI2S的应助被CTbnun采纳,获得10
1秒前
2秒前
Jerry完成签到,获得积分10
2秒前
2秒前
英吉利25发布了新的文献求助20
3秒前
3秒前
3秒前
Peter完成签到,获得积分10
3秒前
巴豆酱完成签到,获得积分10
3秒前
4秒前
65164发布了新的文献求助10
4秒前
4秒前
上官若男的应助被俊逸小海豚采纳,获得10
5秒前
5秒前
端庄的萝发布了新的文献求助10
5秒前
6秒前
saiki完成签到,获得积分10
7秒前
爱笑的鱼完成签到,获得积分10
7秒前
林朗发布了新的文献求助10
7秒前
小L发布了新的文献求助10
8秒前
ytt完成签到,获得积分10
8秒前
bkagyin的应助被CT采纳,获得10
9秒前
脑残骑士老张完成签到,获得积分10
10秒前
科研通AI6.4的应助被讨厌桃子采纳,获得10
10秒前
木木完成签到,获得积分10
10秒前
10秒前
深情安青的应助被ZZZ采纳,获得10
10秒前
lulurie发布了新的文献求助10
11秒前
帆帆发布了新的文献求助10
11秒前
12秒前
12秒前
迅速的大山完成签到 ,获得积分10
13秒前
13秒前
13秒前
无花果的应助被zychaos采纳,获得10
13秒前
Lawrence发布了新的文献求助10
13秒前
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Représentation chimique de la structure des kérogènes et des asphaltènes en fonction de leur origine et de leur degré d'évolution 900
Ecotourism 400
Analytical Separation Science 300
Civilization and War 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8069829
求助须知:如何正确求助?哪些是违规求助? 9490488
关于积分的说明 21359502
捐赠科研通 7638036
什么是DOI,文献DOI怎么找? 3398605
关于科研通互助平台的介绍 2528413
邀请新用户注册赠送积分活动 2436723